Search results
Results from the WOW.Com Content Network
The rate of decline is accelerated when individuals reach 70 years old. [5] By the age of 90, the human brain will have experienced a 15% loss of its initial peak weight. [6] Besides brain atrophy, aging has also been associated with cerebral microbleeds. [3]
The brain is very complex, and is composed of many different areas and types of tissue, or matter. The different functions of different tissues in the brain may be more or less susceptible to age-induced changes. [6] The brain matter can be broadly classified as either grey matter, or white matter.
A new study found that brain aging peaks at 57, 70, and 78. Exercising, eating protein, and sleep can protect your brain against cognitive decline.
Men and women appear to be equally affected. [1] FTD generally presents as a behavioral or language disorder with gradual onset. [4] Signs and symptoms tend to appear in late adulthood, typically between the ages of 45 and 65, although it can affect people younger or older than this. [1]
The cause of the condition is uncertain, but involves the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases. [1] PSP affects about six people per 100,000. [1] The first symptoms typically occur at 60–70 years of age. Males are slightly more likely to be affected than females. [1]
Clinically subcortical dementia usually is seen with features like slowness of mental processing, forgetfulness, impaired cognition, lack of initiative-apathy, depressive symptoms (such as anhedonia, negative thoughts, loss of self-esteem and dysphoria), loss of social skills along with extrapyramidal features like tremors and abnormal movements.
Veronica Brown lived with chronic fatigue, depression, and anxiety for over 10 years before she learned they were early signs of Parkinson's disease. Here's how she found relief after diagnosis.
The treatment will depend on the cause of memory loss, but various drugs to treat Alzheimer's disease have been suggested in recent years. There are four drugs currently approved by the Food and Drug Administration (FDA) for the treatment of Alzheimer's, and they all act on the cholinergic system: Donepezil, Galantamine, Rivastigmine, and ...